# US Cannabis at a Crossroads > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/us-cannabis-at-a-crossroads/ > **Published:** 2026-08-24T17:19:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:46:56-04:00 > **Clinical Summary:** Explore the shift towards CBD-dominant full-spectrum distillates in the US cannabis market and its implications for patient care. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepPainAnxietyNeurologyPolicyCBDResearch Why This Matters This article matters for clinicians and their patients as it discusses the composition of CBD-dominant full spectrum distillates, which are increasingly used in [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/). Understanding these products’ constituents can aid clinicians in making informed decisions about their therapeutic potential and possible interactions with other medications. Furthermore, staying updated on industry trends and product developments is crucial for providing effective and safe care to patients utilizing [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). Clinical Summary This article discusses CBD-dominant full spectrum distillates in US cannabis products, containing approximately 67% to 79% CBD and various minor cannabinoids. The study found that these products may have inconsistent potency due to variable extraction methods and lack of regulatory oversight. Clinicians should be aware of potential variability in product quality and advise patients accordingly when considering CBD-based treatments. Dr. Caplan’s Take “As a seasoned family physician specializing in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), the recent findings on CBD-dominant full spectrum distillates are intriguing. While more human trials and peer-reviewed research are needed to fully understand their potential benefits and risks, these initial results certainly warrant further investigation.” Clinical Perspective 🔬 In the context of evolving cannabis regulations and product offerings, an article titled “US Cannabis at a Crossroads” highlights research on CBD-dominant full spectrum distillates. These products contain a significant percentage (67%-79%) of CBD, along with minor cannabinoids. While the potential [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) of these products are intriguing for healthcare providers, it’s crucial to acknowledge the complexity and variability in their composition. Confounders such as the presence of trace amounts of THC, varying concentrations of other cannabinoids, and inconsistencies in manufacturing processes may impact clinical outcomes. In practice, this underscores the need for ongoing education and vigilance when counseling patients about [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/). Healthcare providers should emphasize the importance of discussing product sources, dosage, and potential interactions with other medications before recommending these treatments. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/sleep/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20US%20Cannabis%20at%20a%20Crossroads%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74754)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74754)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20US%20Cannabis%20at%20a%20Crossroads%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74754)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Louisiana Hemp THC Market Faces Federal Hemp Ban Challenges](https://cedclinic.com/louisiana-thc-drinks-law-federal-hemp-deadline/) - [The Power of Patient Stories: How Lived Experience is Shifting Medical Cannabis Stigma](https://cedclinic.com/the-power-of-patient-stories-how-lived-experience-is-shifting-medical-cannabis-stigma/) - [CED Digest: 23 Items — April 25, 2026](https://cedclinic.com/cannabis-clinical-updates-april-25-2026/) 📰 Source: [https://cannatechtoday.com/us-cannabis-at-a-crossroads/](https://cannatechtoday.com/us-cannabis-at-a-crossroads/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).